SCHEMBL350107

SCHEMBL350107

CCC(C(C)C)S(=O)(=O)C(CC)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6728605 0.79 TP53 (0.30)
SCHEMBL5945423 0.77 TP53 (0.33) TSHR
SCHEMBL7250612 0.77
SCHEMBL7250611 0.77
SCHEMBL20404468 0.77 CA2 (0.39) CA1CA2CA9
SCHEMBL276880 0.77
SCHEMBL1704349 0.77 CA12 (0.33) CA1CA2CA9TSHR
SCHEMBL276314 0.77 CA2 (0.39) CA1CA2CA9
SCHEMBL30443929 0.75
SCHEMBL11682853 0.73 TSHR (0.37) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250357553-A1 LITHIUM ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF LG ENERGY SOLUTION LTD (KR) 2025-11-20 US claimed
EP-4510291-A1 LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR LG Energy Solution, Ltd. (KR) 2025-02-19 EP claimed
WO-2023239074-A1 LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR 주식회사 엘지에너지솔루션 2023-12-14 WO claimed
CN-109496375-B Electrolyte and electrochemical device 株式会社村田制作所 2022-12-02 CN claimed
US-11456485-B2 Sulfone sulfonylimide combinations for advanced battery chemistries THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2022-09-27 US claimed
EP-3477759-B1 ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE COMPRISING THE SAME MURATA MANUFACTURING CO (JP) 2021-07-07 EP claimed
US-20210066754-A1 SULFONE SULFONYLIMIDE COMBINATIONS FOR ADVANCED BATTERY CHEMISTRIES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2021-03-04 US claimed
US-20190157719-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2019-05-23 US claimed
EP-3477759-A1 ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE Murata Manufacturing Co., Ltd. (JP) 2019-05-01 EP claimed
EP-3306730-A1 ELECTROLYTE SOLUTION, METHOD FOR PRODUCING ELECTROLYTE SOLUTION, AND ELECTROCHEMICAL DEVICE Sony Corporation (JP) 2018-04-11 EP claimed
EP-2424030-B1 ELECTROLYTE AND SECONDARY BATTERY USING THE SAME SONY CORP (JP) 2016-06-29 EP claimed
CN-103155261-B Electrolyte and secondary cell SONY CORP. (JP) 2016-03-16 CN claimed
US-9190216-B2 Non-aqueous electrolyte solution for electric double-layer capacitor TAIYO YUDEN CO., LTD. (JP) 2015-11-17 US claimed
US-20140291568-A1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR ELECTRIC DOUBLE-LAYER CAPACITOR TAIYO YUDEN CO., LTD. (JP) 2014-10-02 US claimed
US-20140127594-A1 ELECTROLYTE SOLUTION, METHOD FOR PRODUCING ELECTROLYTE SOLUTION, AND ELECTROCHEMICAL DEVICE SONY CORPORATION (JP) 2014-05-08 US claimed
EP-2631982-A1 ELECTROLYTE AND SECONDARY BATTERY Sony Corporation (JP) 2013-08-28 EP claimed
US-20130202972-A1 ELECTROLYTE AND SECONDARY BATTERY SONY CORPORATION (JP) 2013-08-08 US claimed
EP-2424030-A1 ELECTROLYTE AND SECONDARY BATTERY Sony Corporation (JP) 2012-02-29 EP claimed
US-20120034531-A1 ELECTROLYTE AND SECONDARY BATTERY SONY CORPORATION (JP) 2012-02-09 US claimed
US-3933866-A Process for the manufacture of amino-anthraquinones CIBA-GEIGY AG (CH) 1976-01-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210066754-A1 SULFONE SULFONYLIMIDE COMBINATIONS FOR ADVANCED BATTERY CHEMISTRIES HCN2, NCS1, HCN3 CA1 17/4885CA2 32/4885CA9 15/4885
US-11456485-B2 Sulfone sulfonylimide combinations for advanced battery chemistries HCN2, NCS1, HCN3 CA1 17/4885CA2 32/4885CA9 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.